Busulfan package insert pdf file

busulfan fda approval
busulfan brand namecyclophosphamide package insert
busulfan mechanism of action
busulfex
busulfan smpc
busulfan uses
drugs@fda

BUSULFEX® (busulfan) Injection causes severe and prolonged myelosuppression at the recommended dosage. Hematopoietic progenitor cell transplantation is required Busulfan Injection is a potent cytotoxic medicine that results in profound decrease of blood cells. At the recommended dose, this is the desired effect. Acute and Short-Term Toxicity. Busulfan lowers white blood cell counts, most profoundly in the weeks after the drug is given. This can increase the chance ofWARNING. MYLERAN is a potent drug. It should not be used unless a diagnosis of chronic myelogenous leukemia has been adequately established and the A - Drug Name busulfan. SYNONYM(S): BSF; busulfanum; myelosan. COMMON TRADE NAME(S): Busulfex®; Myleran® back to top. B - Mechanism of Action and Busulfan for Injection is a potent cytotoxic drug that results in profound myelosuppression at the recommended dosage. It should be administered under the WARNING. BUSULFEX (busulfan) Injection is a potent cytotoxic drug that causes profound myelosuppression at the recommended dosage. It should be administered NAME OF THE MEDICINAL PRODUCT. Busilvex 6 mg/ml concentrate for solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION. One ml of concentrate